MR Spectroscopy as a Diagnostic and Outcome Measure in Pain and SCI
MRS
MR Spectroscopy (MRS) as a Diagnostic and Outcome Measure in Pain and SCI
1 other identifier
observational
94
1 country
1
Brief Summary
The goal of this study is to compare the changes that occur in sensation and chemical properties of the brain following SCI between individuals that experience chronic pain and those that do not, and between those with SCI and the able-bodied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2007
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
November 19, 2007
CompletedFirst Posted
Study publicly available on registry
November 21, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedSeptember 17, 2014
September 1, 2014
3.1 years
November 19, 2007
September 16, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Using MR Spectroscopy to measure the concentration of N-acetyl aspartate, glutamate/glutamine, and myo-inositol in the areas of the brain thought to process pain.
Two measures at intervals of 2 to 4 weeks
Study Arms (4)
Group 1
Spinal cord injured with chronic central neuropathic pain.
Group 2
Spinal cord injured without chronic central neuropathic pain.
Group 3
Able-bodied without history of chronic pain of any type
Group 4
Traumatically Brain Injured with a history of pain that onset after their TBI
Eligibility Criteria
Both spinal cord injured (85) and able-bodied (25) subjects will be studied. Of those with spinal cord injury, 60 will be those who experience central neuropathic pain and 25 will not. An additional 25 people who screen positive for mild to moderate TBI symptoms and pain attributable to TBI will be studied.
You may qualify if:
- SCI and neuropathic pain:
- fluent in English
- incomplete or complete traumatic SCI
- the injury must have occurred at least 2 years prior to entering the study
- the injury level must be above L1 and the subjects must have evidence of preserved distal cord functions (lower extremity reflexes and bulbocavernosus or anal wink reflexes)
- must have experienced chronic neuropathic pain at or below the level of injury for a minimum of six months
- must have moderately severe or greater neuropathic pain
- must be able to attend three sessions ranging from 2 to 6 hours over a period of 4 to 5 weeks
- SCI and no neuropathic pain:
- \- same as a., but participants in this group must NOT have unremitting moderate-severe pain and there will only be two sessions ranging from 2 to 6 hours over a period of 1 to 2 weeks
- Able-bodied control subjects:
- fluent in English
- no history of chronic pain conditions
- no substantial brain or body injury
- must be able to attend two sessions ranging from 2 to 6 hours over a period of 1 to 2 weeks
You may not qualify if:
- current pregnancy or women who are contemplating pregnancy
- recent (one-year) history of alcohol or drug abuse
- known intra-cerebral pathology or epilepsy
- MRI findings indicative of intra-cerebral pathology
- significant post-traumatic encephalopathy from head trauma sustained at SCI or cognitive impairment indicative of traumatic brain injury
- current diagnosis of DSM-IV Axis I disorder
- inability to meet the MRI screening requirements (including, but not limited to, the presence of a pacemaker or other electronic devices, prosthesis, artificial limb or joint, shunt, some metal rods, some tattoos, or moderate to severe claustrophobia or anxiety)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- US Department of Veterans Affairslead
- University of Miamicollaborator
Study Sites (1)
VA Medical Center, Miami
Miami, Florida, 33125, United States
Related Publications (6)
Eaton MJ, Widerstrom-Noga E, Wolfe SQ. Subarachnoid Transplant of the Human Neuronal hNT2.19 Serotonergic Cell Line Attenuates Behavioral Hypersensitivity without Affecting Motor Dysfunction after Severe Contusive Spinal Cord Injury. Neurol Res Int. 2011;2011:891605. doi: 10.1155/2011/891605. Epub 2011 Jun 1.
PMID: 21799949BACKGROUNDWiderstrom-Noga E, Pattany PM, Cruz-Almeida Y, Felix ER, Perez S, Cardenas DD, Martinez-Arizala A. Metabolite concentrations in the anterior cingulate cortex predict high neuropathic pain impact after spinal cord injury. Pain. 2013 Feb;154(2):204-212. doi: 10.1016/j.pain.2012.07.022. Epub 2012 Nov 8.
PMID: 23141478RESULTCruz-Almeida Y, Felix ER, Martinez-Arizala A, Widerstrom-Noga EG. Decreased spinothalamic and dorsal column medial lemniscus-mediated function is associated with neuropathic pain after spinal cord injury. J Neurotrauma. 2012 Nov 20;29(17):2706-15. doi: 10.1089/neu.2012.2343. Epub 2012 Aug 27.
PMID: 22845918RESULTFelix ER, Widerstrom-Noga EG. Reliability and validity of quantitative sensory testing in persons with spinal cord injury and neuropathic pain. J Rehabil Res Dev. 2009;46(1):69-83.
PMID: 19533521RESULTCruz-Almeida Y, Alameda G, Widerstrom-Noga EG. Differentiation between pain-related interference and interference caused by the functional impairments of spinal cord injury. Spinal Cord. 2009 May;47(5):390-5. doi: 10.1038/sc.2008.150. Epub 2008 Nov 25.
PMID: 19030010RESULTWiderstrom-Noga EG, Cruz-Almeida Y, Felix ER, Adcock JP. Relationship between pain characteristics and pain adaptation type in persons with SCI. J Rehabil Res Dev. 2009;46(1):43-56.
PMID: 19533519RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eva G. Widerstrom-Noga, DDS PhD
VA Medical Center, Miami
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2007
First Posted
November 21, 2007
Study Start
October 1, 2007
Primary Completion
November 1, 2010
Study Completion
November 1, 2010
Last Updated
September 17, 2014
Record last verified: 2014-09